What does CUSIP 45408X308 represent in this 13F holders report?

CUSIP 45408X308 is the security identifier for IGC - IGC Pharma, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held IGC - IGC Pharma, Inc. - COM NEW in Q4 2018?

2 institutional investors reported IGC - IGC Pharma, Inc. - COM NEW for Q4 2018. Use the holders table for investor-level position and value details.

IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / COM NEW
Total 13F shares: 309,175
Share change: -156,886
Total reported value: $108,000
Price per share: $0.33
Number of holders: 2
Value change: -$1,591,620
Number of buys: 2
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 45408X308:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Carroll Financial Associates, Inc.	13F	Company	— class O/S missing	215,000	$1,386,000	—	30 Sep 2018	13F
Creative Planning	13F	Company	— class O/S missing	65,049	$420,000	—	30 Sep 2018	13F
HSBC HOLDINGS PLC	13F	Company	— class O/S missing	59,730	$385,000	—	30 Sep 2018	13F
SUNTRUST BANKS INC	13F	Company	— class O/S missing	55,000	$355,000	—	30 Sep 2018	13F
JANE STREET GROUP, LLC	13F	Company	— class O/S missing	21,309	$137,000	—	30 Sep 2018	13F
ING GROEP NV	13F	Company	— class O/S missing	15,000	$97,000	—	30 Sep 2018	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	— class O/S missing	11,700	$75,000	—	30 Sep 2018	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	— class O/S missing	8,375	$63,000	—	30 Sep 2018	13F
Advisor Group, Inc.	13F	Company	— class O/S missing	5,232	$33,000	—	30 Sep 2018	13F
CITIGROUP INC	13F	Company	— class O/S missing	3,000	$19,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	— class O/S missing	2,991	$19,000	—	30 Sep 2018	13F
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	1,670	$11,000	—	30 Sep 2018	13F
Parallel Advisors, LLC	13F	Company	— class O/S missing	1,655	$11,000	—	30 Sep 2018	13F
Financial Architects, Inc	13F	Company	— class O/S missing	1,000	$6,000	—	30 Sep 2018	13F
OPTIMUM INVESTMENT ADVISORS	13F	Company	— class O/S missing	1,000	$6,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	— class O/S missing	725	$5,000	—	30 Sep 2018	13F
Advisory Services Network, LLC	13F	Company	— class O/S missing	700	$5,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	500	$3,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	— class O/S missing	100	$1,000	—	30 Sep 2018	13F

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2018

As of 31 Dec 2018, IGC Pharma, Inc. - COM NEW (IGC) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 309,175 shares. The largest 2 holders included Carroll Financial Associates, Inc. and DEARBORN PARTNERS LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

-17

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.